Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Halozyme Therapeutics strengthens commercial supply agreements for rHuPH20

April 8, 2010

Recordati signs marketing agreement with Esteve for pitavastatin

April 8, 2010

Allergan and Serenity Pharmaceuticals to collaborate on development Ser-120 for nocturia

April 8, 2010

Asahi Kasei grants Altheos exclusive rights to AK-138 series compounds for glaucoma

April 7, 2010

Warner Chilcott assumes full commercial responsibility for Actonel in U.S.

April 7, 2010

Teijin and Astellas to market TMX-67 for hyperuricemia in gout patients in China and Hong Kong

April 7, 2010

Takeda and Janssen to comarket Alzheimer's disease therapeutic galantamine in Japan

April 7, 2010

AMAG and Takeda enter into agreement to develop and market Feraheme

April 6, 2010

GSK and Isis to develop RNA-targeted therapeutics for rare and infectious diseases

April 6, 2010

NeurOp and Bristol-Myers Squibb enter drug discovery collaboration

April 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...